Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Michelakis

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
The American Journal of the Medical Sciences|April 20, 2001
Anorectic drugs and pulmonary hypertension from the bedside to the benchE D Michelakis, E K Weir
Current Opinion in Cardiology|June 7, 2006
An evidence-based approach to the management of pulmonary arterial hypertensionStephen L Archer, Evangelos D Michelakis
The New England Journal of Medicine|November 6, 2009
Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertensionStephen L Archer, Evangelos D Michelakis
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 8, 2007
Counterpoint: release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are not the main effectors for full and sustained HPVGaël Y Rochefort, Evangelos D Michelakis
Clinics in Chest Medicine|October 10, 2001
The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channelsE D Michelakis, E K Weir
Journal of Molecular Medicine (Berlin, Germany)|August 25, 2010
The role of mitochondria in pulmonary vascular remodelingPeter Dromparis, Gopinath Sutendra, Evangelos D Michelakis
Current Opinion in Cardiology|February 5, 2010
New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapyFrancois Haddad, Euan Ashley, Evangelos D Michelakis
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 14, 2004
Hypoxic pulmonary vasoconstrictionRohit Moudgil, Evangelos D Michelakis, Stephen L Archer
Circulation|October 1, 2008
Emerging concepts and translational priorities in pulmonary arterial hypertensionEvangelos D Michelakis, Martin R Wilkins, Marlene Rabinovitch
British Journal of Cancer|September 4, 2008
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerE D Michelakis, L Webster, J R Mackey
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
The American Journal of the Medical Sciences|April 20, 2001
Anorectic drugs and pulmonary hypertension from the bedside to the benchE D Michelakis, E K Weir
Current Opinion in Cardiology|June 7, 2006
An evidence-based approach to the management of pulmonary arterial hypertensionStephen L Archer, Evangelos D Michelakis
The New England Journal of Medicine|November 6, 2009
Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertensionStephen L Archer, Evangelos D Michelakis
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 8, 2007
Counterpoint: release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are not the main effectors for full and sustained HPVGaël Y Rochefort, Evangelos D Michelakis
Clinics in Chest Medicine|October 10, 2001
The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channelsE D Michelakis, E K Weir
Journal of Molecular Medicine (Berlin, Germany)|August 25, 2010
The role of mitochondria in pulmonary vascular remodelingPeter Dromparis, Gopinath Sutendra, Evangelos D Michelakis
Current Opinion in Cardiology|February 5, 2010
New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapyFrancois Haddad, Euan Ashley, Evangelos D Michelakis
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 14, 2004
Hypoxic pulmonary vasoconstrictionRohit Moudgil, Evangelos D Michelakis, Stephen L Archer
Circulation|October 1, 2008
Emerging concepts and translational priorities in pulmonary arterial hypertensionEvangelos D Michelakis, Martin R Wilkins, Marlene Rabinovitch
British Journal of Cancer|September 4, 2008
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerE D Michelakis, L Webster, J R Mackey
Pageof 14